269 related articles for article (PubMed ID: 23266795)
41. Legionella pneumophila. A cause of severe community-acquired pneumonia.
Falcó V; Fernández de Sevilla T; Alegre J; Ferrer A; Martínez Vázquez JM
Chest; 1991 Oct; 100(4):1007-11. PubMed ID: 1914547
[TBL] [Abstract][Full Text] [Related]
42. Impact of pre-hospital antibiotic use on community-acquired pneumonia.
Simonetti AF; Viasus D; Garcia-Vidal C; Grillo S; Molero L; Dorca J; Carratalà J
Clin Microbiol Infect; 2014 Sep; 20(9):O531-7. PubMed ID: 24707906
[TBL] [Abstract][Full Text] [Related]
43. Procalcitonin kinetics in Legionella pneumophila pneumonia.
de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC
Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643
[TBL] [Abstract][Full Text] [Related]
44. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Grau S; Antonio JM; Ribes E; Salvadó M; Garcés JM; Garau J
Int J Antimicrob Agents; 2006 Sep; 28(3):249-52. PubMed ID: 16870401
[TBL] [Abstract][Full Text] [Related]
45. [Legionella pneumophila serogroup 1].
Sabrià M
Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):391-3. PubMed ID: 14525702
[No Abstract] [Full Text] [Related]
46. Retrospective study of 30 cases of Legionella pneumonia in the Kansai region.
Maniwa K; Taguchi Y; Ito Y; Mishima M; Yoshida S
J Infect Chemother; 2006 Oct; 12(5):272-6. PubMed ID: 17109091
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of a Legionella outbreak emerged in a recently opening hotel].
Erdoğan H; Arslan H
Mikrobiyol Bul; 2013 Apr; 47(2):240-9. PubMed ID: 23621724
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of procalcitonin in Legionella pneumonia.
Haeuptle J; Zaborsky R; Fiumefreddo R; Trampuz A; Steffen I; Frei R; Christ-Crain M; Müller B; Schuetz P
Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):55-60. PubMed ID: 18677519
[TBL] [Abstract][Full Text] [Related]
49. Legionella pneumonia caused by Legionella pneumophila serogroup 2: second case report in Japan.
Furugen M; Koide M; Baba M; Sato Y; Teruya H; Naha Y; Tamayose M; Akamine M; Uchihara T; Atsumi E; Haranaga S; Yara S; Higa F; Tateyama M; Fujita J
J Infect Chemother; 2008 Apr; 14(2):161-5. PubMed ID: 18622682
[TBL] [Abstract][Full Text] [Related]
50. Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia.
Miyashita N; Horita N; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kiyota H; Watanabe A
J Infect Chemother; 2019 Jun; 25(6):407-412. PubMed ID: 30935766
[TBL] [Abstract][Full Text] [Related]
51. Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy.
Falcone M; Russo A; Tiseo G; Cesaretti M; Guarracino F; Menichetti F
Infection; 2021 Apr; 49(2):321-325. PubMed ID: 33315182
[TBL] [Abstract][Full Text] [Related]
52. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Piso RJ; Arnold C; Bassetti S
Swiss Med Wkly; 2013; 143():w13870. PubMed ID: 24089030
[TBL] [Abstract][Full Text] [Related]
53. A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem.
Nishizuka M; Suzuki H; Ara T; Watanabe M; Morita M; Sato C; Tsuchida F; Seto J; Amemura-Maekawa J; Kura F; Takeda H
J Infect Chemother; 2014 Jun; 20(6):390-3. PubMed ID: 24629522
[TBL] [Abstract][Full Text] [Related]
54. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.
Sopena N; Sabrià-Leal M; Pedro-Botet ML; Padilla E; Dominguez J; Morera J; Tudela P
Chest; 1998 May; 113(5):1195-200. PubMed ID: 9596294
[TBL] [Abstract][Full Text] [Related]
55. The public health implications of a sporadic case of culture-proven Legionnaires' disease.
Young M; Smith H; Gray B; Huang B; Barten J; Towner C; Plowman S; Afshar B; Fry N; Blair B; Savill J; McCall B
Aust N Z J Public Health; 2005 Dec; 29(6):513-7. PubMed ID: 16366060
[TBL] [Abstract][Full Text] [Related]
56. [Community outbreak of pneumonia due to Legionella pneumophila: importance of monitoring hospital cooling towers].
de Olalla PG; Gracia J; Rius C; Caylà JA; Pañella H; Villabí JR; Guix J; Pellicer T; Ferrer D; Cusi M; Pelaz C; Sabrià M;
Enferm Infecc Microbiol Clin; 2008 Jan; 26(1):15-22. PubMed ID: 18208761
[TBL] [Abstract][Full Text] [Related]
57. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy.
Gacouin A; Le Tulzo Y; Lavoue S; Camus C; Hoff J; Bassen R; Arvieux C; Heurtin C; Thomas R
Intensive Care Med; 2002 Jun; 28(6):686-91. PubMed ID: 12107671
[TBL] [Abstract][Full Text] [Related]
58. Seroprevalence of Legionella pneumophila in pneumonia patients in four major hospitals in Trinidad and Tobago.
Nagalingam NA; Adesiyun AA; Swanston WH; Bartholomew M
West Indian Med J; 2005 Dec; 54(6):375-8. PubMed ID: 16642654
[TBL] [Abstract][Full Text] [Related]
59. Legionella pneumophila DNA in serum samples during Legionnaires' disease in relation to C-reactive protein levels.
van de Veerdonk FL; de Jager CP; Schellekens JJ; Huijsmans CJ; Beaumont F; Hermans MH; Wever PC
Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):371-6. PubMed ID: 18855027
[TBL] [Abstract][Full Text] [Related]
60. Legionella pneumophila serogroup 3 infection: importance of serology.
Khanna N; Meikle A; Gillespie L; Edwards G; Lindsay D
Scott Med J; 2012 Aug; 57(3):182. PubMed ID: 22859812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
